The IQE website contains all the elements required under Rule 26 of the London Stock Exchange's AIM rules concerning Company Information Disclosure.
This page was last updated on 8 May 2026.
Significant shareholders:
| Shareholder/Beneficial Owner | Shares | % ISC |
|---|---|---|
| Lombard Odier Investment Managers | 139,179,293 | 14.20 |
| Artisan Partners | 130,367,739 | 13.30 |
| Interactive Brokers | 78,890,674 | 8.05 |
| Hargreaves Lansdown, stockbrokers | 62,222,682 | 6.35 |
| Mr Richard Griffiths | 63,173,492 | 5.79 |
| Interactive Investor | 55,978,915 | 5.71 |
| Dr Andrew Nelson* | 35,398,548 | 3.61 |
as at 30 April 2026
Quoted: AIM (London Stock Exchange)
Other Exchanges / Trading Platforms: The Company is not listed on any other exchanges or trading platforms.
Number of securities in issue: 979,886,435 Ordinary shares.
Shares not in public hands: Insofar as the Company is aware, the percentage of securities that is not in public hands is 15.0%, these being held by directors, their families and significant shareholders.
Own shares held in treasury: The Company holds 4,115 Ordinary Shares in treasury.
Details on any restrictions on the transfer of securities: There are no restrictions on the transfer of securities.
Applicable code(s): The Company is subject to the UK City Code on Takeovers and Mergers. The Code is administered by The Panel and Takeovers in Mergers.
* Per the Company’s RNS announcement of 11 May 2020, 12,121,711 Ordinary Shares of Dr Nelson’s total beneficial interest are subject to a Sale and Repurchase Agreement with Equities First Holdings.